IntelGenx Technologies Corp. (CVE:IGX – Get Free Report) rose 1.8% during trading on Monday . The stock traded as high as C$0.60 and last traded at C$0.58. Approximately 11,848 shares were traded during trading, a decline of 79% from the average daily volume of 56,279 shares. The stock had previously closed at C$0.57.
IntelGenx Technologies Price Performance
The firm has a market capitalization of C$87.32 million and a PE ratio of -7.44. The firm’s fifty day moving average price is C$0.58 and its 200 day moving average price is C$0.58. The company has a current ratio of 2.77, a quick ratio of 2.69 and a debt-to-equity ratio of 164.62.
IntelGenx Technologies Company Profile
IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine. The company's products under development comprise INT0004/2006, an antidepressant; INT0046/2018 for adult use; INT0007/2006 for the treatment of erectile dysfunction; INT0010/2006 for the treatment of neuropathic pain and nausea in cancer patients; INT0027/2011 to treat opioid addition; INT0036/2013 for schizophrenia; and INT0043/2015 to treat Alzheimer's disease; and INT0048/2020 for animal health.
See Also
- Five stocks we like better than IntelGenx Technologies
- Are Penny Stocks a Good Fit for Your Portfolio?
- 2 Stocks to Gain From Trump Universal Tariffs on Critical Imports
- Why Are These Companies Considered Blue Chips?
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Delta Can Fly to New Highs in 2025; Here’s Why
Receive News & Ratings for IntelGenx Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntelGenx Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
